ATE206129T1 - Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper - Google Patents

Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper

Info

Publication number
ATE206129T1
ATE206129T1 AT90916421T AT90916421T ATE206129T1 AT E206129 T1 ATE206129 T1 AT E206129T1 AT 90916421 T AT90916421 T AT 90916421T AT 90916421 T AT90916421 T AT 90916421T AT E206129 T1 ATE206129 T1 AT E206129T1
Authority
AT
Austria
Prior art keywords
human
protein
production
directed against
antibodies directed
Prior art date
Application number
AT90916421T
Other languages
English (en)
Inventor
Charles R King
Patricia S Steeg
Lance A Liotta
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE206129T1 publication Critical patent/ATE206129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
AT90916421T 1989-10-18 1990-10-17 Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper ATE206129T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42280189A 1989-10-18 1989-10-18
PCT/US1990/005849 WO1991005793A1 (en) 1989-10-18 1990-10-17 Production and use of human nm23 protein and antibodies therefor

Publications (1)

Publication Number Publication Date
ATE206129T1 true ATE206129T1 (de) 2001-10-15

Family

ID=23676440

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90916421T ATE206129T1 (de) 1989-10-18 1990-10-17 Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper

Country Status (10)

Country Link
US (3) US6423836B1 (de)
EP (1) EP0495910B1 (de)
JP (2) JP2758500B2 (de)
AT (1) ATE206129T1 (de)
AU (1) AU643971B2 (de)
CA (1) CA2067797C (de)
DE (1) DE69033810T2 (de)
DK (1) DK0495910T3 (de)
ES (1) ES2164634T3 (de)
WO (1) WO1991005793A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770386A (en) * 1992-05-20 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
AU6947298A (en) * 1997-04-03 1998-10-22 Joslin Diabetes Center Inc. Modulating the rad-nm23 interaction
WO2002094376A2 (en) * 2001-05-22 2002-11-28 Duke University Compositions and methods for promoting or inhibiting ndpk
GB0124145D0 (en) * 2001-10-08 2001-11-28 Bayer Ag Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
CN101918556B (zh) 2007-09-04 2013-06-12 株式会社普罗赛尔制药 可穿透细胞的nm23重组蛋白、编码其的多核苷酸以及包含其的抗转移组合物
JP2014517690A (ja) * 2011-05-09 2014-07-24 ミネルバ バイオテクノロジーズ コーポレーション 遺伝子操作した成長因子変異体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35097A (en) * 1862-04-29 Improvement in machines for upsetting tires
US4808528A (en) * 1983-05-19 1989-02-28 Karl Tryggvason Antibody composition for the detection of malignant cells with metastatic cell activity
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4816400A (en) * 1983-05-19 1989-03-28 Karl Tryggvason Basement membrane collagen degrading enzyme and method of purifying same
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
AU5197986A (en) * 1984-11-30 1986-06-18 Whitehead Institute For Biomedical Research Transmissible, mammalian genes associated with tumor metastasis
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
US5049662A (en) 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
JPH01156999A (ja) * 1988-09-03 1989-06-20 Dainippon Pharmaceut Co Ltd ヒト癌壊死因子
WO1991006671A1 (fr) * 1989-10-31 1991-05-16 Institut Pasteur Moyens pour la detection de cellules hautement proliferatives
FR2653781B1 (fr) * 1989-10-31 1992-02-07 Pasteur Institut Procede de synthese de derives d'adenosine phosphate et derives obtenus.
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein

Also Published As

Publication number Publication date
EP0495910A1 (de) 1992-07-29
DK0495910T3 (da) 2002-01-14
JPH04506457A (ja) 1992-11-12
JP3295358B2 (ja) 2002-06-24
JP2758500B2 (ja) 1998-05-28
CA2067797C (en) 1997-03-04
WO1991005793A1 (en) 1991-05-02
CA2067797A1 (en) 1991-04-19
EP0495910A4 (en) 1993-09-15
EP0495910B1 (de) 2001-09-26
DE69033810D1 (de) 2001-10-31
DE69033810T2 (de) 2002-03-28
US6087117A (en) 2000-07-11
AU643971B2 (en) 1993-12-02
JPH10212299A (ja) 1998-08-11
US6423836B1 (en) 2002-07-23
ES2164634T3 (es) 2002-03-01
US6329198B1 (en) 2001-12-11
AU7042491A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ATE299180T1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
DE69111596D1 (de) Verwendung von zwitterionen zur mobilisierung isoelektrisch fokussierter ampholytzonen.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
DK130387A (da) Transglutaminase inhibitorer
DE69031656D1 (de) Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung
GR3026219T3 (en) Mouse monoclonal antibodies
DE60135315D1 (de) In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide
DE69738045D1 (de) Verwendung von cetrorelix zur behandlung von benigne prostatahypertrophie und prostatakrebs
ATE206129T1 (de) Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper
ATE35416T1 (de) Derivate des glycerophosphocholins und glycerophosphoethanolamins, ihre herstellung und verwendung.
ATE120372T1 (de) Antikörper für die antilymphozyten- antikörpertherapie.
IE900141L (en) Acyl-peptide hydrolase and methods of production and use
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
DE58901722D1 (de) Verwendung von 2-oxo-pyrrolidin-1-acetamid zur bestimmung der glomerulaeren filtrationsrate beim menschen.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
ATE134874T1 (de) Synoviale phospholipasen
DE69315341D1 (de) Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
DE60135232D1 (de) Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen
ATE295874T1 (de) Differenzierungsfaktor der hypophyse und methoden zu seiner verwendung.
SE9604439D0 (sv) New receptor
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DE69710476T2 (de) Alkaloidglykoside zur verwendung als arzneimittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time